Will the FDA approve any psychedelic substance for medical use this year? (Before 2027)

Kalshi Health › FDA & drugs Closes Dec 31 · $3 today · $66.9K traded · $15.5K at stake · prices read 4 min ago

The odds

16%chance▲ 1

How the odds have moved

Yes: 19% on Oct 20, 16% now.

Each outcome's chance over time on Kalshi. The dots along the bottom are headlines about its subject: point at one to read it.

Every outcome

Outcome Chance Day Bid Ask Pays Contracts
Yes 16% ▲ 1 15¢ 17¢ $5.88 417.9K

"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".

The news: FDA

Search ›
  • FDA has finalized its guidance on apps related to drugsSTAT · 2 days agoSTAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts…
  • FDA to pull common but ineffective cold medicine from marketCBS News · 2 days agoNovember 7, 2024 / 12:32 PM EST / CBS News The Food and Drug Administration announced Wednesday that it would seek to pull a widely used ingredient in cough and cold medicines from the market, after the agency's scientists concluded that…
  • Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addictionSTAT · 2 days agoSTAT Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction Online platforms, experts say, can shift the burden of vetting unapproved drugs on to patients Katie covers the impact of health technology on…
  • Nasal decongestant phenylephrine, found in many over-the-counter cold and allergy medicines, doesn't work, FDA experts sayCBS News · 2 days agoUpdated on: September 16, 2023 / 8:59 PM EDT / AP The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest…
  • Is my GLP-1 safe? What to know about FDA's crackdown on copycat drugsUSA TODAY · 4 days agoCheaper copycat versions of the popular weight-loss drugs Wegovy and Zepbound are still being marketed to consumers. The thriving market for "compounded" GLP-1 medications persists despite warnings from federal drug regulators, a recall…
  • FDA allowing food companies to switch to salt substituteCBS News · 4 days agoCBS News FDA allowing food companies to switch to salt substitute Chicago still accepting submissions for official 2026 Christmas tree Metra UP-NW train hits vehicle in Des Plaines, delays service Expert weighs in after nearly 1,000 birds…
  • FDA Finalizes NDIN Identity and Safety GuidanceThe National Law Review · 48 h agoOn October 19, 2026, FDA released a final guidance document titled “New Dietary Ingredient (NDI) Notifications and Related Issues; Identity and Safety Informa - On October 19, 2026, FDA released a final guidance document titled “New…
  • FDA Issues Final Guidance on Mandatory RecallsHappi · 44 h agohappi Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere. “No substantive changes” from the draft guidance issued in December 2025, according to the Agency. After reviewing public comments…
  • FDA Accepts Troriluzole NDA Resubmission for Spinocerebellar Ataxia@neurology_live · 35 h agoThe FDA set a first quarter 2027 goal date for troriluzole in spinocerebellar ataxia and plans an advisory committee after a 2025 complete response letter. The FDA has accepted the resubmitted new drug application (NDA) for troriluzole…
  • FDA approves new tricuspid valve repair systemhealiotwo · 2 days agoEdwards Lifesciences announced that the FDA approved its system for tricuspid valve repair. The repair system (PASCAL Precision) is indicated for patients with symptomatic severe tricuspid regurgitation despite optimal medical therapy at…
  • Onvansertib Receives FDA Orphan Drug Designation for CMML@onclive · 47 h agoTHE COUNTDOWN IS ON FDA grants orphan drug designation to onvansertib for relapsed or refractory CMML, boosting development of the PLK1 inhibitor after early signals of activity. Onvansertib has received orphan drug designation from the US…
  • FDA grants accelerated approval to groundbreaking rectal cancer immunotherapyNews-Medical · 42 h agoFor patients facing rectal cancer, standard treatment has often involved chemotherapy, radiation and major surgery, which can result in permanent colostomies, infertility, incontinence and other lifelong complications. This new…

Related markets

All fda & drugs ›

Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Search. Prices read from the venues 3 min ago. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.

Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Search, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Search index; prices of stocks, rates and coins from 4Search Finance. Nothing here is betting, financial or investment advice. Terms of use.